NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 874 filers reported holding NOVARTIS A G in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $230,000 | +9.0% | 2,430 | 0.0% | 0.10% | -1.0% |
| Q3 2019 | $211,000 | -35.5% | 2,430 | -32.1% | 0.10% | -38.1% |
| Q2 2019 | $327,000 | -36.1% | 3,580 | -32.8% | 0.17% | -37.8% |
| Q1 2019 | $512,000 | +1.8% | 5,324 | -9.1% | 0.27% | -13.7% |
| Q4 2018 | $503,000 | -13.4% | 5,857 | -13.1% | 0.31% | -7.9% |
| Q3 2018 | $581,000 | +14.1% | 6,738 | 0.0% | 0.34% | +24.5% |
| Q2 2018 | $509,000 | -11.0% | 6,738 | -4.7% | 0.27% | -11.1% |
| Q1 2018 | $572,000 | -9.4% | 7,073 | -6.0% | 0.31% | -4.7% |
| Q4 2017 | $631,000 | -2.3% | 7,523 | 0.0% | 0.32% | -5.6% |
| Q3 2017 | $646,000 | +2.9% | 7,523 | 0.0% | 0.34% | -0.9% |
| Q2 2017 | $628,000 | +12.3% | 7,523 | 0.0% | 0.34% | -4.4% |
| Q1 2017 | $559,000 | -99.9% | 7,523 | 0.0% | 0.36% | +16.5% |
| Q4 2016 | $547,975,000 | +0.4% | 7,523 | +8.7% | 0.31% | 0.0% |
| Q3 2016 | $545,947,000 | -5.2% | 6,923 | -0.6% | 0.31% | -6.1% |
| Q2 2016 | $575,910,000 | +111727.2% | 6,963 | -3.5% | 0.33% | +9.3% |
| Q1 2016 | $515,000 | – | 7,215 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |